Finland· FI-REL-REL38012
Truscient
A bmp-2 product containing dibotermin alfa, registered in Finland by Zoetis Belgium.
Checked against Fimea (Finland) on
Informational only — not a medical device.
The record
At a glance
Fimea (Finland)- Active substance
- Dibotermin alfa
- Manufacturer
- Zoetis Belgium
- Country
- Finland (FI)
- ATC code
- QM05BC01
- ATC class
- BMP-2
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Dibotermin alfa in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumInductOs 1.5 mg/mlMedtronic Biopharma
- SwitzerlandInductOs 1.5 mg/ml, poudre 12 mg, solvant et matrice pour matrice pour implantationMedtronic BioPharma Sàrl
- CzechiaINDUCTOSMedtronic BioPharma B.V., Heerlen
- United KingdomInductOs 12mg powder and solvent and matrix for implantation matrixMedtronic Ltd
- FranceINDUCTOS 1,5 mg/ml, poudre, solvant et matrice pour matrice implantableMEDTRONIC BIOPHARMA (PAYS-BAS)
- SwedenInductOs 1,5 mg/ml Pulver, vätska och matrix till matrix för implantationMedtronic BioPharma B.V.
- IrelandInductOs 1.5 mg/ml powder, solvent and matrix for implantation matrixMedtronic BioPharma B.V.
- IcelandInductOsMedtronic BioPharma B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Inductos
- Liechtenstein · Inductos
- Norway · Inductos
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/66a2c780-b76c-4b30-a059-3df5cc9da69b GET /v1/drugs/66a2c780-b76c-4b30-a059-3df5cc9da69b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "implantaatti",
"route": null,
"ddd_unit": null,
"strength": "0.66 mg",
"atc_label": "BMP-2",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/2/11/136/001",
"fimea_rel_id": "REL38012",
"authorised_at": "2011-12-14"
}See everything about dibotermin alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.